Federal Register Notice: FDA is making available a draft guidance for industry entitled Protecting the Rights, Safety, and Welfare of Study Subjects — Supervisory Responsibilities of Investigators. The guidance is intended to assist investigators in meeting their responsibilities with respect to protecting human subjects and ensuring the integrity of data in the conduct of clinical investigations. It also clarifies FDA's expectations on the investigator's responsibility for supervising a clinical study in which some study tasks are delegated to employees of the investigator or to outside parties. To download the guidance, click here. To view this notice, click here.